TY  - GEN
AU  - Fouqué,Amélie
AU  - Jean,Mickael
AU  - Weghe,Pierre van de
AU  - Legembre,Patrick
TI  - Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers
SN  - 2212-3970
PY  - 2017///0313
KW  - Animals
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Clinical Trials as Topic
KW  - Drug Discovery
KW  - Female
KW  - Humans
KW  - Molecular Structure
KW  - Molecular Targeted Therapy
KW  - Phosphatidylinositol 3-Kinase
KW  - metabolism
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Protein Kinase Inhibitors
KW  - Signal Transduction
KW  - drug effects
KW  - Structure-Activity Relationship
KW  - TOR Serine-Threonine Kinases
KW  - antagonists & inhibitors
KW  - Triple Negative Breast Neoplasms
KW  - drug therapy
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.2174/1574892811666160519113731
ER  -